Innovative Medicines & Oncology Practice during Covid at MENARegions Policy analysis

Abstract

Oncology practice during COVID -19 pandemic faced many challenges one of the major challenges is adaptation of treatment protocols for achieving following objectives. Managing system capacity, Enhancement of patient’s outcomes (quality of life – economic value – clinical effectiveness). And utilizing the resources during this hard times. Previous objectives raised many questions about nature of treatment protocols should be implemented during COVID -19. Pandemic and how innovative medicines can achieve the previous objectives.